Searchable abstracts of presentations at key conferences in endocrinology

ea0056p855 | Pituitary - Clinical | ECE2018

Hypopituitarism in primary empty sella

Tomsic Karin Zibar , Deskin Marin , Kraljevic Ivana , Dusek Tina , Solak Mirsala , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

Empty sella is characterized by the radiological appearance of an enlarged or deformed sella turcica which is completely or partially filled with cerebrospinal fluid resulting in a displacement of the normal pituitary gland. Primary empty sella (PES) refers to the empty sella appearance of unknown etiology, diagnosed after excluding a history of previous pituitary pathology. The prevalence of hypopituitarism in empty sella syndrome varies between 2 and 32% in different publish...

ea0099p417 | Adrenal and Cardiovascular Endocrinology | ECE2024

Germline targeted next-generation sequencing in patients with adrenal incidentalomas

Messina Erika , Puglisi Soraya , Scatolini Maria , Tomaiuolo Pasquale , Nekić Anja Barač , Morelli Valentina , Alessi Ylenia , Tomsic Karin Zibar , Palmieri Serena , Ferrau Francesco , Grosso Enrico , Pia Anna , Reimondo Giuseppe , Chiodini Iacopo , Kastelan Darko , Terzolo Massimo

Background: The advances in next-generation sequencing (NGS) technologies and bioinformatic analysis have shed light on genetic alterations, either of germline or somatic origin, in many disorders, including adrenocortical diseases. However, our knowledge on genomic characteristics in benign adrenal tumors of serendipitous discovery (adrenal incidentalomas) remain scarce.The aim of this study was to understand the pathogenic role of germline variants in adrenal incidentalomas....

ea0099p2 | Adrenal and Cardiovascular Endocrinology | ECE2024

Prospective, multi-country, observational study of patients with endogenous Cushing’s syndrome exposed to Ketoconazole (using the existing European Registry on Cushing’s Syndrome (ERCUSYN)), to assess drug use, safety and effectiveness

Webb Susan , Santos Alicia , Aulinas Maso Anna , Tomsic Karin Zibar , Amaral Claudia , Feelders Richard , Ragnarsson Oskar , Ferrante Emanuele , Ceccato Filippo , Chabre Olivier , Cristante Justine , Hanzu Felicia , Reincke Martin , Chanson Philippe , Tabarin Antoine , Sequeira Duarte Joao , Guelho Daniela , Fajardo Carmen , Bostnavaron Martine , Bou Nader Myriam , Bertherat Jerome , Brue Thierry

Background: Ketoconazole is a steroidogenesis inhibitor approved in Europe for the treatment of endogenous Cushing’s syndrome (CS) based on retrospective studies published over 3 decades. We present interim data from the first prospective observational, multicenter, international study on ketoconazole, a non-interventional PASS (Post-Authorization Safety study) requested by EMA at the time of registration to confirm ketoconazole good tolerance and effectiveness. This stud...